Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
REITs Drag Real Estate Stocks Down
Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $18
Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $18
Sabra Health Care REIT Inc (SBRA) Q2 2024 Earnings Call Highlights: Strong NOI Growth and ...
Hurricane Milton Puts $30B of Florida Muni Debt at Risk - Report
Real Estate Stocks End in Red Amid Geopolitical Tensions
Sabra Healthcare REIT Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
Best Real Estate Growth Stocks as the Sector Is Seeing a Revival
Here Are the Most Attractive High-yield Dividend Stocks Right Now
Citigroup Upgrades Sabra Health Care REIT to Buy From Neutral, Price Target Is $20
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Citi analyst Nicholas Joseph upgrades $Sabra Health Care REIT Inc(SBRA.US)$ to a buy rating, and adjusts the target price from $15 to $20.According to TipRanks data, the analyst has a success rate
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Maintains Target Price $18
Truist Financial analyst Michael Lewis maintains $Sabra Health Care REIT Inc(SBRA.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Truist Financial analyst Michael Lewis maintains $Sabra Health Care REIT Inc(SBRA.US)$ with a buy rating, and sets the target price at $18.According to TipRanks data, the analyst has a success rate
Sabra Health Care REIT, Inc. to Participate in the BofA Securities 2024 Global Real Estate Conference
Sabra Healthcare REIT Price Target Raised to $17.00/Share From $15.00 by Scotiabank